Seminars in Pediatric Neurology
Volume 14, Issue 1 , Pages 34-45 , March 2007

Atypical Patterns of Inheritance

  • Andrea L. Gropman, MD

      Affiliations

    • Department of Neurology, Center for Neuroscience and Behavioral Medicine, Children’s National Medical Center, The George Washington University, Washington, DC.
    • Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
    • Corresponding Author InformationAddress reprint Requests to Andrea Gropman, MD, Department of Neurology, Center for Neuroscience and Behavioral Medicine, Children’s National Medical Center, 111 Michigan Avenue, N.W., Washington, DC 20010.
    • ,
  • David R. Adams, MD, PhD

      Affiliations

    • Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.

References 

  1. Dipple KM, McCabe ER. Phenotypes of patients with “simple” Mendelian disorders are complex traits: Thresholds, modifiers, and systems dynamics. Am J Hum Genet. 2000;66:1729–1735
  2. Summers KM. Relationship between genotype and phenotype in monogenic diseases: Relevance to polygenic diseases. Hum Mutat. 1996;7:283–293
  3. Grünfeld JP. Monogenic renal diseases: A clinical introduction. J Nephrol. 2002;15:S43–S46
  4. van Heyningen V, Yeyati PL. Mechanisms of non-Mendelian inheritance in genetic disease. Hum Mol Genet. 2004;13:R225–R233
  5. Dipple KM, McCabe ER. Modifier genes convert “simple” Mendelian disorders to complex traits. Mol Genet Metab. 2000;71:43–50
  6. Cutting GR. Modifier genetics: Cystic fibrosis. Ann Rev Genomics Hum Genet. 2005;6:237–260
  7. Badano JL, Katsanis N. Beyond Mendel: An evolving view of human genetic disease transmission. Nat Rev Genet. 2002;3:779–789
  8. Nadeau JH. Modifier genes and protective alleles in humans and mice. Curr Opin Genet Dev. 2003;13:290–295
  9. Slavotinek A, Biesecker LG. Genetic modifiers in human development and malformation syndromes, including chaperone proteins. Hum Mol Genet. 2003;12:R45–R50
  10. Johnson KR, Zheng QY, Noben-Trauth K. Strain background effects and genetic modifiers of hearing in mice. Brain Res. 2006;1091:79–88
  11. Haston CK, Tsui LC. Loci of intestinal distress in cystic fibrosis knockout mice. Physiol Genom. 2003;12:79–84
  12. Agarwal S, Moorchung N. Modifier genes and oligogenic disease. J Nippon Med Sch. 2005;72:326–334
  13. Li J, Hayden MR, Almqvist EW, et al. A genome scan for modifiers of age at onset in Huntington’s disease: The HD MAPS study. Am J Hum Genet. 2003;73:682–687
  14. Li JL, Hayden MR, Warby SC, et al. Genome-wide significance for a modifier of age at neurological onset in Huntington disease at 6q23-24: The HD MAPS Study. BMC Med Genet. 2006;7:71
  15. Acton JD, Wilmott RW. Phenotype of CF and the effects of possible modifier genes. Paediatr Resp Rev. 2001;2:332–339
  16. Sontag MK, Accurso FJ. Gene modifiers in pediatrics: application to cystic fibrosis. Adv Pediatr. 2004;51:5–36
  17. Slieker MG, Sanders EAM, Rijkers GT, et al. Disease modifying genes in cystic fibrosis. J Cyst Fibros. 2005;4:7–13
  18. Martin JB, Gusella JF. Huntington’s disease (Pathogenesis and management). N Engl J Med. 1986;315:1267–1276
  19. Gonzalez-Alegre P, Afifi AK. Clinical characteristics of childhood-onset (juvenile) Huntington disease: Report of 12 patients and review of the literature. J Child Neurol. 2006;21:223–229
  20. Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993;72:971–983
  21. Andrew SE, Goldberg YP, Kremer B, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington’s disease. Nat Genet. 1993;4:398–403
  22. Duyao M, Ambrose C, Myers R, et al. Trinucleotide repeat length instability and age of onset in Huntington’s disease. Nat Genet. 1993;4:387–392
  23. Snell RG, MacMillan JC, Cheadle JP, et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington’s disease. Nat Genet. 1993;4:393–397
  24. Ranen NG, Stine OC, Abbott MH, et al. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet. 1995;57:593–602
  25. Brinkman RR, Mezei MM, Theilmann J, et al. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet. 1997;60:1202–1210
  26. Djousse L, Knowlton B, Hayden MR, et al. Evidence for a modifier of age of onset age in Huntington disease linked to the HD gene in 4p16. Neurogenetics. 2004;5:109–114
  27. Verger A, Quinlan KG, Crofts LA, et al. Mechanisms directing the nuclear localization of the CtBP family proteins. Mol Cell Biol. 2006;26:4882–4894
  28. Kegel KB, Meloni AR, Yi Y, et al. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. Biol Chem. 2002;277:7466–7476
  29. Naze P, Vuillaume I, Destee A, et al. Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington’s disease. Neurosci Lett. 2002;328:1–4
  30. Rubinsztein DC, Leggo J, Chiano M, et al. Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci U S A. 1997;94:3872–3876
  31. MacDonald ME, Vonsattel JP, Shrinidhi J, et al. Evidence for the GluR6 gene associated with younger onset age of Huntington’s disease. Neurology. 1999;53:1330–1332
  32. Steffan JS, Agrawal N, Pallos J, et al. SUMO modification of Huntingtin and Huntington’s disease pathology. Science. 2004;304:100–104
  33. Johnson ES. Protein modification by SUMO. Annu Rev Biochem. 2004;73:355–382
  34. Arning L, Kraus PH, Valentin S, et al. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics. 2005;6:25–28
  35. Leavitt BR, van Raamsdonk JM, Shehadeh J, et al. Wild-type huntingtin protects neurons from excitotoxicity. J Neurochem. 2006;96:1121–1129
  36. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science. 1989;245:1066–1073
  37. Morral N, Bertranpetit J, Estivill X, et al. The origin of the major cystic fibrosis mutation (delta F508) in European populations. Nat Genet. 1994;7:169–175
  38. Bronsveld I, Mekus F, Bijman J, et al. Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings. J Clin Invest. 2001;108:1705–1715
  39. Chillon M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med. 1995;332:1475–1480
  40. Cuppens H, Lin W, Jaspers M, et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes (The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation). J Clin Invest. 1998;101:487–496
  41. Gan KH, Veeze HJ, van den Ouweland AM, et al. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med. 1995;333:95–99
  42. De Braekeleer M, Allard C, Leblanc JP, et al. Genotype-phenotype correlation in cystic fibrosis patients compound heterozygous for the A455E mutation. Hum Genet. 1997;101:208–211
  43. Kiesewetter S, Macek M, Davis C, et al. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet. 1993;5:274–278
  44. Massie RJ, Poplawski N, Wilcken B, et al. Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C. Eur Respir J. 2001;17:1195–1200
  45. Chmiel JF, Drumm ML, Konstan MW, et al. Pitfall in the use of genotype analysis as the sole diagnostic criterion for cystic fibrosis. Pediatrics. 1999;103:823–826
  46. Kubesch P, Dork T, Wulbrand U, et al. Genetic determinants of airways’ colonisation with Pseudomonas aeruginosa in cystic fibrosis. Lancet. 1993;341:189–193
  47. Davidson DJ, Dorin JR, McLachlan G, et al. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet. 1995;9:351–357
  48. Zielenski J, Corey M, Rozmahel R, et al. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet. 1999;22:128–129
  49. Salvatore F, Scudiero O, Castaldo G. Genotype-phenotype correlation in cystic fibrosis: The role of modifier genes. Am J Med Genet. 2002;111:88–95
  50. Pirzada O, Taylor C. Modifier genes and cystic fibrosis liver disease. Hepatology. 2003;37:714
  51. Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration. 2000;67:117–133
  52. Mekus F, Ballmann M, Bronsveld I, et al. Categories of delta F508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res. 2000;3:277–293
  53. Aron Y, Polla BS, Bienvenu T, et al. HLA class II polymorphism in cystic fibrosis (A possible modifier of pulmonary phenotype). Am J Respir Crit Care Med. 1999;159:1464–1468
  54. Drumm ML, Konstan MW, Schluchter MD, et al. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med. 2005;353:1443–1453
  55. Howe KL, Wang A, Hunter MM, et al. TGF beta down-regulation of the CFTR: A means to limit epithelial chloride secretion. Exp Cell Res. 2004;298:473–484
  56. Garred P, Presler T, Madsen HO, et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest. 1999;104:431–437
  57. Davies JC, Aturner MW, Klein N. Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles. Eur Respir J. 2004;24:798–804
  58. Gabolde M, Guilloud-Bataille M, Feingold J, et al. Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: Cohort study. BMJ. 1999;319:1166–1167
  59. Grasemann H, Knauer N, Buscher R, et al. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med. 2000;162:2172–2176
  60. Grasemann H, Storm van’s GK, Gartig S, Kirsch M, et al. Nasal nitric oxide levels in cystic fibrosis patients are associated with a neuronal NO synthase (NOS1) gene polymorphism. Nitric Oxide. 2002;6:236–241
  61. Grasemann H, Storm van’s GK, Buscher R, et al. Endothelial nitric oxide synthase variants in cystic fibrosis lung disease. Am J Respir Crit Care Med. 2003;167:390–394
  62. Mahadeva R, Stewart S, Bilton D, et al. Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease. Thorax. 1998;53:1022–1024
  63. Mahadeva R, Sharples L, Ross-Russell RI, et al. Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis. Thorax. 2001;56:53–58
  64. Wojnarowski C, Frischer T, Hofbauer E, et al. Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation. Eur Respir J. 1999;14:1136–1144
  65. Arkwright PD, Laurie S, Super M, et al. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax. 2000;55:459–462
  66. Katsanis N, Ansley SJ, Badano JL, et al. Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science. 2001;293:2256–2259
  67. Laurence JZ, Moon RC. Four cases of retinitis pigmentosa occurring in the same family and accompanied by general imperfection of development. Ophthalmol Rev. 1966;2:2–41
  68. Green JS, Parfrey PS, Harnett JD, et al. The cardinal manifestations at Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med. 1989;321:1002–1009
  69. Beales PL, Elcioglu N, Woolf AS, et al. New criteria for improved diagnosis of Bardet-Biedl syndrome: Results of a population survey. J Med Genet. 1999;36:437–446
  70. Beales PL, Katsanis N, Lewis RA, et al. Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci. Am J Hum Genet. 2001;68:606–616
  71. Riise R, Andreasson S, Borgastrom MK, et al. Intrafamilial variation of the phenotype in Bardet-Biedl syndrome. Br J Ophthalmol. 1997;81:378–385
  72. Nishimura DY, Searby CC, Carmi R, et al. Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet. 2001;10:865–874
  73. Beales PL, Katsanis N, Lewis RA, et al. Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci. Am J Hum Genet. 2001;68:606–616
  74. Carmi R, Elbedour K, Stone EM, et al. Phenotypic differences among patients with Bardet-Biedl syndrome linked to three different chromosome loci. Am J Med Genet. 1995;59:199–203
  75. David A, Bitoun P, Lacombe D, et al. Hydrometrocolpos and polydactyly: a common neonatal presentation of Bardet-Biedl and McKusick-Kaufman syndromes. J Med Genet. 1999;36:599–603
  76. Katsanis N, Beales PL, Woods MO, et al. Mutations in MKKS cause obesity, retinal dystrophy and renal malformation associated with Bardet-Biedl syndrome. Nat Genet. 2000;26:67–70
  77. Slavotinek AM, Stone EM, Mykytyn K, et al. Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet. 2000;26:15–16
  78. Mykytyn K, Nishimura DY, Searby CC, et al. Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome. Nat Genet. 2000;31:435–438
  79. Mykytyn K, Braun T, Carmi R, et al. Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat Genet. 2001;28:188–191
  80. Stoetzel C, Laurier V, Faivre L, et al. BBS8 is rarely mutated in a cohort of 128 Bardet-Biedl syndrome families. J Hum Genet. 2006;51:81–84
  81. Stoetzel C, Laurier V, Davis EE, et al. BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nat Genet. 2006;38:521–524
  82. Katsanis N, Ansley SJ, Badano JL, et al. Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science. 2001;293:2256–2259
  83. Badano JL, Kim JC, Hoskins BE, et al. Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. Hum Mol Genet. 2003;12:1651–1659
  84. Mykytyn K, Nishimura DY, Searby CC, et al. Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1). Am J. Hum Genet. 2003;72:429–437
  85. Smaoui N, Chaabouni M, Sergeev YV, et al. Screening of the eight BBS genes in Tunisian families: No evidence of triallelism. Invest Ophthalmol Vis Sci. 2006;47:3487–3495
  86. Beales PL, Badano JL, Ross AJ, et al. Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. Am J Hum Genet. 2003;72:1187–1199
  87. Katsanis N, Eichers ER, Ansley SJ, et al. BBS4 is a minor contributor to Bardet-Biedl syndrome and may also participate in triallelic inheritance. Am J Hum Genet. 2002;71:22–29
  88. Fauser S, Munz M, Besch D. Further support for digenic inheritance in Bardet-Biedl syndrome. J Med Genet. 2003;40:e104
  89. Hichri H, Stoetzel C, Laurier V, et al. Testing for triallelism: analysis of six BBS genes in a Bardet-Biedl syndrome family cohort. Eur J Hum Genet. 2005;13:607–616
  90. Katsanis N. The oligogenic properties of Bardet-Biedl syndrome. Hum Mol Genet. 2004;13:R65–R71
  91. Beales PL. Lifting the lid on Pandora’s box: The Bardet-Biedl syndrome. Curr Opin Genet Dev. 2005;15:315–323
  92. Nance WE. The genetics of deafness. Ment Retard Dev Disabil Res Rev. 2003;9:109–119
  93. Friedman TB, Griffith AJ. Human nonsyndromic sensorineural deafness. Annu Rev Genomics Hum Genet. 2003;4:341–402
  94. Denoyelle F, Weil D, Maw MA, et al. Prelingual deafness: High prevalence of a 30delG mutation in the Connexin 26 gene. Hum Mol Genet. 1997;6:2173–2177
  95. Green GE, Scott DA, McDonald JM, et al. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA. 1999;281:2211–2216
  96. Abe S, Usami S, Shinkawa H, Kelley PM, et al. Prevalent Connexin 26 gene (GJB2) mutations in Japanese. J Med Genet. 2000;37:41–43
  97. Rabionet R, Gasparini P, Estivill X. Molecular genetics of hearing impairment due to mutations in Gap Junction genes encoding beta connexins. Hum Mutat. 2000;16:190–202
  98. Zelante L, Gasparini P, Estivill X, et al. Connexin 26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet. 1997;6:1605–1659
  99. Scott DA, Kraft ML, Carmi R, et al. Identification of mutations in the connexin 26 gene that cause autosomal recessive nonsyndromic hearing loss. Hum Mutat. 1998;11:387–394
  100. Estivill X, Fortina P, Surrey S, et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet. 1998;351:394–398
  101. Morell RJ, Kim HJ, Hood LJ, et al. Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med. 1998;339:1500–1505
  102. Guilford P, Ben Arab S, Blanchard S, et al. A nonsyndrome form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13q. Nat Genet. 1994;6:24–28
  103. Kelsell DP, Dunlop J, Stevens HP, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature. 1997;387:80–83
  104. Lerer I, Sagi M, Ben-Neriah Z, et al. A deletion mutation in GJB6 cooperating with a GJB2 mutation in trans in non-syndromic deafness: A novel founder mutation in Ashkenazi Jews. Hum Mutat. 2001;18:460
  105. Del Castillo I, Villamar M, Moreno-Pelayo MA, et al. A deletion involving the Connexin 30 Gene in nonsyndromic hearing impairment. N Engl J Med. 2002;353:1298–1303
  106. Pandya A, Arnos KS, Xia XJ, et al. Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands. Genet Med. 2003;5:295–303
  107. Gualandi E, Ravani A, Berto A, et al. Occurrence of del(GIB6-D13S1830) mutation in Italian non-syndromic hearing loss patients carrying a single GJB2 mutated allele. Acta Otolaryngol. 2004;552(Suppl):29–34
  108. Stevenson VA, Iato M, Milunsky JM. Connexin-30 Deletion anaylsis in connexin-26 heterozygotes. Genet Test. 2003;7:151–154
  109. Grifa A, Wagner CA, D’Ambrosio L, et al. Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA34 locus. Nat Genet. 1999;23:16–18
  110. Del Castillo I, Moreno-Pelayo MA, Del Castillo FJ, et al. Prevalence and evolutionary origins of the del(GJB6-D13S1830) mutation in the DFNB1 locus in hearing-impaired subjects: a multicenter study. Am J Hum Genet. 2003;73:1452–1458
  111. Del Castillo I, Moreno-Pelayo MA, Del Castillo FJ, et al. Prevalence and evolutionary origins of the del (GJB6-D13S1830) mutation in the DFNB1 locus in hearing-impaired subjects: A multicenter study. Am J Hum Genet. 2003;73:1452–1458
  112. Richard G, Rouan F, Willoughby CE, et al. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet. 2002;70:1341–1348
  113. Oguchi T, Ohtsuka A, Hashimoto S, et al. Clinical features of patients with GJB2 (connexin 26) mutations: severity of hearing loss is correlated with genotypes and protein expression patterns. J Hum Genet. 2005;50:76–83
  114. Delaval K, Feil R. Epigenetic regulation of mammalian genomic imprinting. Curr Opin Genet Dev. 2004;14:188–195
  115. Constañcia M, Pickard B, Kelsey G, et al. Imprinting mechanisms. Genome Res. 2006;8:881–900
  116. Verona RI, Mann MR, Bartolomei MS. Genomic imprinting:intricacies of epigenetic regulation in clusters. Annu Rev Cell Dev Biol. 2003;19:237–259
  117. Delaval K, Wagschal A, Reil R. Epigenetic deregulation of imprinting in congenital diseases of aberrant growth. Bioessays. 2006;28:453–459
  118. Gicquel C, Rossignol S, Cabrol S, et al. Epimutation of the telomeric imprinting center region on chromosome11p15 in Silver-Russell syndrome. Nat Genet. 2005;37:1003–1007
  119. Eggermann T, Schonherr N, Meyer E, et al. Epigenetic mutations in 11p15 in Silver-Russell syndrome are restricted to the telomeric imprinting domain. J Med Genet. 2005;43:615-161
  120. Bliek J, Terhal P, van den Bogaard MJ, et al. Hypomethylation of the H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype. Am J Hum Genetic. 2006;78:604–614
  121. Weksberg R, Shuman C, Smith AC. Beckwith-Wiedemann Syndrome. Am J Med Genet. 2005;137C:12–23
  122. Sait SN, Nowak NJ, Singh-Kahlon P, et al. Localization of Beckwith-Wiedemann and rhabdoid tumor chromosome rearrangements to a defined interval in chromosome band 11p15.5. Genes Chromosomes Cancer. 1994;11:97–105
  123. Brown KW, Gardner A, Williams JC, et al. Paternal origin of 11p15 duplications in the Beckwith-Wiedemann syndrome (A new case and review of the literature). Cancer Genet Cytogenet. 1992;58:66–67
  124. Slavotinek A, Gaunt L, Donnai D. Paternally inherited duplications of 11p15.5 and Beckwith–Wiedemann syndrome. J Med Genet. 1997;34:819–826
  125. Smith AC, Rubin T, Shuman C, et al. New chromosome 11p15 epigenotypes identified in male monozygotic twins with Beckwith-Wiedemann syndrome. Cytogenet Genome Res. 2006;113:313–317
  126. Gaston V, Le Bouc Y, Soupre V, et al. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome. Eur J Hum Genet. 2001;9:409–418
  127. Machin GA. Some causes of genotypic and phenotypic discordance in monozygotic twin pairs. Am J Med Genet. 1996;61:216–228
  128. DeBaun MR, Niemitz EL, Feinberg AP. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet. 2003;72:156–160
  129. Gicquel C, Gaston V, Mandelbaum J, et al. In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene. Am J Hum Genet. 2003;72:1338–1341
  130. Maher ER, Brueton LA, Bowdin SC, et al. Beckwith–Wiedemann syndrome and assisted reproduction technology (ART). J Med Genet. 2003;40:62–64
  131. Schuman C, Smith AC, Weksberg R. “Beckwith-Wiedemann Syndrome.”. GeneReviews. 2005;Available at: http://www.genereviews.org. Accessed January 4, 2007.
  132. Wang Q, Chen Q, Towbin JA. Genetics, molecular mechanisms and management of the long QT syndrome. Ann Med. 1998;30:58–65
  133. Neyroud N, Tesson F, Denjoy I, et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet. 1997;15:186–189
  134. Tyson J, Tranebjaerg L, McEntagart M, et al. Mutational spectrum in the cardioauditory syndrome of Jervall and Lange-Nielsen. Hum Genet. 2000;107:499–503(erratum in Hum Genet 108:75, 2001)

PII: S1071-9091(06)00164-1

doi: 10.1016/j.spen.2006.11.007

Seminars in Pediatric Neurology
Volume 14, Issue 1 , Pages 34-45 , March 2007

Article Tools

* Image Usage & Resolution